BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23182687)

  • 1. Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality.
    McCowan C; Munro AJ; Donnan PT; Steele RJ
    Eur J Cancer; 2013 Mar; 49(5):1049-57. PubMed ID: 23182687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study.
    Fraser DM; Sullivan FM; Thompson AM; McCowan C
    Br J Cancer; 2014 Jul; 111(3):623-7. PubMed ID: 24945997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does low-dose aspirin use for cardiovascular disease prevention reduce colorectal cancer deaths? A comparison of two cohorts in the Florence district, Italy.
    Ventura L; Miccinesi G; Barchielli A; Manneschi G; Puliti D; Mantellini P; Orso F; Zappa M
    Eur J Cancer Prev; 2018 Mar; 27(2):134-139. PubMed ID: 27845951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin extends life of some patients with colorectal cancer.
    Printz C
    Cancer; 2013 Feb; 119(3):472-3. PubMed ID: 23341305
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland.
    Macarthur M; Sharp L; Hold GL; Little J; El-Omar EM
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1613-8. PubMed ID: 16030091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
    Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R
    N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer.
    Peleg II; Maibach HT; Brown SH; Wilcox CM
    Arch Intern Med; 1994 Feb; 154(4):394-9. PubMed ID: 8117171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of aspirin and the risk of mortality in patients with prostate cancer.
    Assayag J; Pollak MN; Azoulay L
    J Urol; 2015 Apr; 193(4):1220-5. PubMed ID: 25463991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
    Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
    J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
    Bardia A; Ebbert JO; Vierkant RA; Limburg PJ; Anderson K; Wang AH; Olson JE; Vachon CM; Cerhan JR
    J Natl Cancer Inst; 2007 Jun; 99(11):881-9. PubMed ID: 17551148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin use and mortality from cancer in a prospective cohort study.
    Ratnasinghe LD; Graubard BI; Kahle L; Tangrea JA; Taylor PR; Hawk E
    Anticancer Res; 2004; 24(5B):3177-84. PubMed ID: 15510608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of follow-up colon examination among a population-based cohort of colorectal cancer patients.
    Rulyak SJ; Lieberman DA; Wagner EH; Mandelson MT
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):470-6; quiz 407. PubMed ID: 17270502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin and folic acid for the prevention of recurrent colorectal adenomas.
    Logan RF; Grainge MJ; Shepherd VC; Armitage NC; Muir KR;
    Gastroenterology; 2008 Jan; 134(1):29-38. PubMed ID: 18022173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can aspirin reduce the risk of colorectal cancer in people with diabetes? A population-based cohort study.
    Lin CC; Lai MS; Shau WY
    Diabet Med; 2015 Mar; 32(3):324-31. PubMed ID: 25252097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: a Danish cohort study.
    Friis S; Poulsen AH; Sørensen HT; Tjønneland A; Overvad K; Vogel U; McLaughlin JK; Blot WJ; Olsen JH
    Cancer Causes Control; 2009 Jul; 20(5):731-40. PubMed ID: 19122977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden.
    Larsson SC; Giovannucci E; Wolk A
    Br J Cancer; 2006 Nov; 95(9):1277-9. PubMed ID: 17060932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin use and survival after diagnosis of colorectal cancer.
    Chan AT; Ogino S; Fuchs CS
    JAMA; 2009 Aug; 302(6):649-58. PubMed ID: 19671906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and disease outcome of UICC stages I-III colorectal cancer patients at Siriraj Hospital.
    Techawathanawanna S; Nimmannit A; Akewanlop C
    J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S189-98. PubMed ID: 22574549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.